Glaucoma Clinical Trial
Official title:
Ultrasonic Evaluation of Ocular Tissues
The objective of this research program is to improve diagnosis and treatment monitoring of ophthalmic disease by improving diagnostic ultrasound techniques. The program explores the use of novel signal and imaging processing techniques towards this end.
This study involves the diagnosis of several eye diseases, as follows:
Glaucoma:
1. Morphometry and spectral parameter assays: Clinical correlative studies in primary and
secondary glaucoma subgroups: This is a volunteer study to obtain volumetric
measurements of age-related changes in the ciliary body and individual ciliary muscle
components. The study will provide baseline values for treatment monitoring studies of
glaucoma therapeutics. There is minimal risk that the ultrasound procedure may reveal
an occult ocular disease process, but the probability is very small. Patients will be
informed and assisted in obtaining appropriate care if any abnormality is seen.
2. Morphometry and spectral parameter assays: Ciliary body drug interactions in patients
with initial diagnosis of open angle glaucoma: This study will attempt to document
changes in anterior segment functional anatomy related to medical management of
glaucoma. We hypothesize that several classes of anti-glaucoma drugs produce permanent
modification of ciliary muscle vasculature that is related in turn to loss of drug
efficacy over time. Data from COAG patients will be compared with age and sex matched
normals. Participation in the study will not effect the ongoing glaucoma therapy of
patients.
Accommodation:
3. Accommodative function in young emmetropes and transitional presbyopes: This is a
volunteer study to develop a descriptive model of the human eye's focusing mechanism
based on ultrasound morphometric measurements and spectral parameter assays. This study
will measure dynamic changes in ciliary body spectral assays (size, CQ2) during
calibrated accommodative tasks in volunteers with good amplitude of accommodation and
those with accommodative loss do to aging and model 3-D conformal changes in anterior
segment structures during accommodation. There is minimal risk that the ultrasound
procedure may reveal an occult ocular disease process, but the probability is very
small. Patients will be informed and assisted in obtaining appropriate care if any
abnormality is seen.
Ocular Tumors
4. Tumors of the iris and ciliary body: This is an observational study of growth pattern
changes in anterior melanoma for the purpose of identifying prognostic variables
associated with rapid tumor growth. A percentage of small melanomas are observed for
periods of up to several years before demonstrable growth will suggest more aggressive
treatment. In the clinical ultrasound practice many patients with these tumors are seen
at 3 to 6 month intervals to provide the ophthalmic oncologist with updated tumor
volume data. We will examine changes in the ultrasound scattering structure of these
tumors over time and their correlation with volume changes. The on-going research data
are not released as part of the clinical ultrasound report.
Age-related Macular Degeneration
5. Posterior examinations: age-related macular degeneration: This study will examine the
use of higher frequency (20-30 MHz) ultrasound in the early diagnosis of Age-related
macular degeneration. Our hypothesis is that early changes in the choriocapillaries and
choroid vascular density and conformation can be detected with high-frequency spectral
assays. We will obtain ultrasound scans at frequencies of 20 MHz or more, as well as
OCT and fundus photographs. Similar numbers of age-matched control subjects will be
examined. Measurements of retinal and choroidal thickness profiles in the peri-macular
region will be made. Spectral data will be used for morphologic vascular analysis (size
and shape). Statistical comparison will be made using parametric and non-parametric
methods between control and AMD groups.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A |